ES2133095B1 - Acidos alquilidenglutaminicos con propiedades farmaceuticas. - Google Patents

Acidos alquilidenglutaminicos con propiedades farmaceuticas.

Info

Publication number
ES2133095B1
ES2133095B1 ES009700642A ES9700642A ES2133095B1 ES 2133095 B1 ES2133095 B1 ES 2133095B1 ES 009700642 A ES009700642 A ES 009700642A ES 9700642 A ES9700642 A ES 9700642A ES 2133095 B1 ES2133095 B1 ES 2133095B1
Authority
ES
Spain
Prior art keywords
sub
optionally substituted
alkyl
phenyl
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES009700642A
Other languages
English (en)
Other versions
ES2133095A1 (es
Inventor
Tercero Concepcion Pedregal
Esteban Almudena Rubio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly SA
Original Assignee
Lilly SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly SA filed Critical Lilly SA
Priority to ES009700642A priority Critical patent/ES2133095B1/es
Priority to EP98302168A priority patent/EP0867430A3/en
Priority to US09/046,445 priority patent/US5990165A/en
Priority to CA002233077A priority patent/CA2233077A1/en
Priority to JP10075357A priority patent/JPH10279542A/ja
Publication of ES2133095A1 publication Critical patent/ES2133095A1/es
Application granted granted Critical
Publication of ES2133095B1 publication Critical patent/ES2133095B1/es
Anticipated expiration legal-status Critical
Withdrawn - After Issue legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Acidos alquilidenglutámicos con propiedades farmacéuticas. Una composición farmacéutica de fórmula (I), en la que n es 1 ó 2, R sup,1 es -CO sub,2 H, R sub,2 es hidrógeno o alquilo C sub,1 -C sub,4 y R sub,3 es hidrógeno, alquilo C sub,1-10 , alquenilo C sub,2-10 , fenilo opcionalmente sustituido, fenil-alquilo C sub,1-4 opcionalmente sustituido, fenil alquenilo C sub,2-10 opcionalmente sustituido, (fenil opcionalmente sustituido) sub,2 -alquilo C sub,1-4 , cicloalquilo C sub,3-7 opcionalmente sustituido, cicloalquilo C sub,3-7 opcionalmente sustituido-alquilo C sub,1-4 o cicloalquilo C sub,3-7 opcionalmente sustituido-alquenilo C sub,2-10 o R sup,2 y R sup,3 juntos con el átomo de carbono al que están unidos, forman un grupo cicloalquilo C sub,4-7 opcionalmente sustituido; o una sal o un éster del mismo.
ES009700642A 1997-03-25 1997-03-25 Acidos alquilidenglutaminicos con propiedades farmaceuticas. Withdrawn - After Issue ES2133095B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES009700642A ES2133095B1 (es) 1997-03-25 1997-03-25 Acidos alquilidenglutaminicos con propiedades farmaceuticas.
EP98302168A EP0867430A3 (en) 1997-03-25 1998-03-24 Glutamic acid derivatives and pharmaceutical compositions for the treatment of central nervous system disorders
US09/046,445 US5990165A (en) 1997-03-25 1998-03-24 Pharmaceutical compounds
CA002233077A CA2233077A1 (en) 1997-03-25 1998-03-24 Pharmaceutical compounds
JP10075357A JPH10279542A (ja) 1997-03-25 1998-03-24 製薬化合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009700642A ES2133095B1 (es) 1997-03-25 1997-03-25 Acidos alquilidenglutaminicos con propiedades farmaceuticas.

Publications (2)

Publication Number Publication Date
ES2133095A1 ES2133095A1 (es) 1999-08-16
ES2133095B1 true ES2133095B1 (es) 2000-04-01

Family

ID=8298736

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009700642A Withdrawn - After Issue ES2133095B1 (es) 1997-03-25 1997-03-25 Acidos alquilidenglutaminicos con propiedades farmaceuticas.

Country Status (5)

Country Link
US (1) US5990165A (es)
EP (1) EP0867430A3 (es)
JP (1) JPH10279542A (es)
CA (1) CA2233077A1 (es)
ES (1) ES2133095B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5343519B2 (es) * 1974-05-22 1978-11-20
GB9324872D0 (en) * 1993-12-03 1994-01-19 Univ Pasteur Pharmaceutical compounds

Also Published As

Publication number Publication date
EP0867430A3 (en) 1998-12-09
EP0867430A2 (en) 1998-09-30
CA2233077A1 (en) 1998-09-25
ES2133095A1 (es) 1999-08-16
JPH10279542A (ja) 1998-10-20
US5990165A (en) 1999-11-23

Similar Documents

Publication Publication Date Title
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
CO5011115A1 (es) Compuestos y metodos quimioquina
CO5150235A1 (es) Agentes tiromimetricos antiobesidad roaceticos que los contiene
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
BR9814548A (pt) "derivados de alfa-aminoamida úteis como agentes analgésicos"
AR045782A2 (es) Derivados de piperidina que tienen actividad farmaceutica
CO4940462A1 (es) 4,5-diarilimidazoles 2-sustituidos
AR034858A1 (es) Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
CO5180557A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas .
PE20000129A1 (es) 11 beta-halogeno-estratrienos sustituidos en 7 alfa, asi como el procedimiento para elaborar preparados farmaceuticos que contienen tales 11 beta-halogeno-estratrienos sustituidos en 7 alfa
CO5040216A1 (es) Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen
GT200100196A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7.
BRPI0312882B8 (pt) derivados de pleuromutilina e composição farmacêutica
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
BRPI0406924A (pt) Composições de fragrância
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
FI971992A0 (fi) 3-aryyliakryylihappoestereiden käyttö elotonta orgaanista materiaalia valolta suojaavina ja sen stabiloivina aineina
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
CO5140099A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
ES2133095B1 (es) Acidos alquilidenglutaminicos con propiedades farmaceuticas.
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
AR018675A1 (es) Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento.
CO5280088A1 (es) Inhibidores de proteasa

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990816

Kind code of ref document: A1

Effective date: 19990816

FA2A Application withdrawn

Effective date: 20001025